DE69229573D1 - Monoklonaler Antikörper, Polypeptide und deren Herstellung - Google Patents

Monoklonaler Antikörper, Polypeptide und deren Herstellung

Info

Publication number
DE69229573D1
DE69229573D1 DE69229573T DE69229573T DE69229573D1 DE 69229573 D1 DE69229573 D1 DE 69229573D1 DE 69229573 T DE69229573 T DE 69229573T DE 69229573 T DE69229573 T DE 69229573T DE 69229573 D1 DE69229573 D1 DE 69229573D1
Authority
DE
Germany
Prior art keywords
production
polypeptides
monoclonal antibodies
cancer
motility
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69229573T
Other languages
English (en)
Other versions
DE69229573T2 (de
Inventor
Shuichi Ikeyama
Masaru Koyama
Masaharu Senoo
Masayuki Miyake
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MIYAKE, MASAYUKI, KYOTO, JP
Takeda Pharmaceutical Co Ltd
Original Assignee
Miyake Inc
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miyake Inc, Takeda Chemical Industries Ltd filed Critical Miyake Inc
Publication of DE69229573D1 publication Critical patent/DE69229573D1/de
Application granted granted Critical
Publication of DE69229573T2 publication Critical patent/DE69229573T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DE69229573T 1991-04-12 1992-04-09 Monoklonaler Antikörper, Polypeptide und deren Herstellung Expired - Lifetime DE69229573T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP7999691 1991-04-12
JP8539691 1991-04-17
JP2232192 1992-02-07

Publications (2)

Publication Number Publication Date
DE69229573D1 true DE69229573D1 (de) 1999-08-19
DE69229573T2 DE69229573T2 (de) 2000-01-13

Family

ID=27283799

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69229573T Expired - Lifetime DE69229573T2 (de) 1991-04-12 1992-04-09 Monoklonaler Antikörper, Polypeptide und deren Herstellung

Country Status (5)

Country Link
US (2) US5439886A (de)
EP (1) EP0508417B1 (de)
AT (1) ATE182178T1 (de)
CA (1) CA2065797C (de)
DE (1) DE69229573T2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004007685A2 (en) * 2002-07-12 2004-01-22 The University Of Tennessee Research Foundation Methods of modifying behavior of cd9-expressing cells
JP6627141B2 (ja) * 2015-12-31 2020-01-08 ディヴェロップメント センター フォー バイオテクノロジー ベニバナボロギク抽出物を調製する方法、それにより調製された抽出物、及び抽出物の使用
EP3400245A1 (de) 2016-01-08 2018-11-14 Aimm Therapeutics B.V. Therapeutischer anti-cd9-antikörper
US20220229072A1 (en) 2019-06-04 2022-07-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of cd9 as a biomarker and as a biotarget in glomerulonephritis or glomerulosclerosis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3319751A1 (de) * 1983-05-31 1984-12-06 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verfahren zur gewinnung von gegen tumorantigene gerichteten monoklonalen antikoerpern und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
CA2065797C (en) 2007-06-26
US5439886A (en) 1995-08-08
DE69229573T2 (de) 2000-01-13
CA2065797A1 (en) 1992-10-13
EP0508417A2 (de) 1992-10-14
US5776727A (en) 1998-07-07
EP0508417B1 (de) 1999-07-14
ATE182178T1 (de) 1999-07-15
EP0508417A3 (en) 1993-05-12

Similar Documents

Publication Publication Date Title
DK0554344T3 (da) Farmaceutisk præparat til behandling eller forebyggelse af en malign tumor
ATE251644T1 (de) Mit monoklonalem antikörper anti-her2 induzierte apoptosis
ATE177758T1 (de) Synthetische peptide, antikörper dagegen und ihre verwendung
FI864427A0 (fi) Menetelmä polypeptidin valmistamiseksi, joka on komplementaarinen ainakin osalle alkuperäistä peptidiä tai proteiinia, ja komplementaarisen polypeptidin käyttö
ZA874558B (en) Monoclonal antibodies to unreduced,nonenzymatically-glycated proteins
DE3581288D1 (de) Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen.
DE69229573D1 (de) Monoklonaler Antikörper, Polypeptide und deren Herstellung
FI925321A (fi) Immunodiagnostiskt ledinflammationstest
DE69224134D1 (de) Monoklonale Antikörper gegen Hepatitis-C-Virus
ATE79632T1 (de) Tumorverbundenes antigen.
ES2179824T3 (es) Anticuerpos humanizados reactivos contra el antigeno gpiib/iiia.
ATE97959T1 (de) Monoklonale antikoerper gegen menschliche alphaatrialnatri¨retic-polypeptide und entsprechende hybridome, deren herstellung und verwendung.
ES2061973T3 (es) Anticuerpos monoclonales que reconocen la region n-terminal de polipeptido natriuretico auricular, su preparacion y uso.
ATE103973T1 (de) Gamma-atriales, natriuretisches polypeptid erkennende monoklonale antikoerper, solche antikoerper produzierende hybridome und deren herstellung und verwendung.
Masathien et al. Production and characterization of monoclonal antibodies neutralizing the postsynaptic neurotoxin 3 from Naja kaouthia venom
GR890100333A (en) Antihuman antigen antibodies

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: TAKEDA PHARMACEUTICAL CO. LTD., OSAKA, JP

Owner name: MIYAKE, MASAYUKI, KYOTO, JP

R071 Expiry of right

Ref document number: 508417

Country of ref document: EP